YUNAH LEE: Open Payments
NPI 1396382933 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 15 payments from 8 companies in 2025. Trend: 2023 $531 · 2024 $25 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 5 | $175 |
| Axsome Therapeutics, Inc. | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Neos Therapeutics, LP | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Biogen, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Corium, LLC | 1 | $11 |
Products named: Dyanavel XR, Auvelity, REXULTI, Adzenys XR-ODT, TRINTELLIX, ZURZUVAE, CAPLYTA, Azstarys.
Industry payments across IL — which companies pay providers there.
